Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 21
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Role of palmitoylation on the neuronal glycine transporter GlyT2.

  • Felipe, R
  • Sarmiento-Jiménez, J
  • Camafeita, E
  • Vázquez, J
  • López-Corcuera, B
The neuronal glycine transporter GlyT2 removes glycine from the synaptic cleft through active Na, Cl, and glycine cotransport contributing to the termination of the glycinergic signal as well as supplying substrate to the presynaptic terminal for the maintenance of the neurotransmitter content in synaptic vesicles. Patients with mutations in the human GlyT2 gene (SLC6A5), develop hyperekplexia or startle disease (OMIM 149400), characterized by hypertonia and exaggerated startle responses to trivial stimuli that may have lethal consequences in the neonates as a result of apnea episodes. Post-translational modifications in cysteine residues of GlyT2 are an aspect of structural interest we analyzed. Our study is compatible with a reversible and short-lived S-acylation in spinal cord membranes, detectable by biochemical and proteomics methods (acyl-Rac binding and IP-ABE) confirmed with positive and negative controls (palmitoylated and non-palmitoylated proteins). According to a short-lived modification, direct labeling using click chemistry was faint but mostly consistent. We have analyzed the physiological properties of a GlyT2 mutant lacking the cysteines with high prediction of palmitoylation and the mutant is less prone to be included in lipid rafts, an effect also observed upon treatment with the palmitoylation inhibitor 2-bromopalmitate. This work demonstrates there are determinants of lipid raft inclusion associated with the GlyT2 mutated cysteines, which are presumably modified by palmitoylation.
Repisalud
Publication Reseña (Review)

Metabolic homeostasis of tissue macrophages across the lifespan.

  • Wculek, Stefanie K
  • Forisch, Stephan
  • Miguel, Verónica
  • Sancho, David
Macrophages are present in almost all organs. Apart from being immune sentinels, tissue-resident macrophages (TRMs) have organ-specific functions that require a specialized cellular metabolism to maintain homeostasis. In addition, organ-dependent metabolic adaptations of TRMs appear to be fundamentally distinct in homeostasis and in response to a challenge, such as infection or injury. Moreover, TRM function becomes aberrant with advancing age, contributing to inflammaging and organ deterioration, and a metabolic imbalance may underlie TRM immunosenescence. Here, we outline current understanding of the particular metabolic states of TRMs across organs and the relevance for their function. Moreover, we discuss the concomitant aging-related decline in metabolic plasticity and functions of TRMs, highlighting potential novel therapeutic avenues to promote healthy aging.
Repisalud
Publication Artículo científico (JournalArticle)

Deciphering the landscape of post-translational modifications in the centrosome upon T cell activation.

  • Lozano-Prieto, Marta
  • Jorge, Inmaculada
  • Camafeita, Emilio
  • Devesa, Cristina A
  • Barrero-Rodríguez, Rafael
  • Calvo, Enrique
  • Laguillo-Gómez, Andrea
  • Pertusa, Clara
  • Martin-Cofreces, Noa B
  • Vázquez, Jesús
  • Sánchez-Madrid, Francisco
The shift from quiescent to effector T cells (TC) is controlled at the translational level. Post-translational modifications (PTMs) are key factors in the diversification of protein function. Advancements in mass spectrometry-based proteomics enable proteome-wide, hypothesis-free quantitative PTM analysis. Current research highlights the centrosome role in TC activation. Here the diversity of PTMs in the TC centrosome is studied by analyzing centrosome-enriched fractions from human resting and activated T lymphoblasts. Our results show that oxidative modifications predominate in this organelle, with tryptophan as the most frequently oxidized residue. These PTMs are enriched in proteins involved in translation, vesicular trafficking, cytoskeleton organization, among others. We also demonstrate the existence of PTM changes on specific protein regions during TC activation in Myh9 (hyperoxidized), and Gzma (hypoxidized). These hyper- or hypoxidized proteins display distinct functional distributions. Our study provides the first comprehensive PTM mapping of the TC centrosome, underscoring the PTM regulatory role in TC activation.
Repisalud
Publication Artículo científico (JournalArticle)

Arabidopsis INHIBITOR OF GROWTH 2 promotes flowering by regulating NuA4-dependent H4 acetylation levels at FT and SOC1.

  • Barrero-Gil, Javier
  • Mouriz, Alfonso
  • Piqueras, Raquel
  • Tian, Yingnan
  • López, Juan A
  • Vázquez, Jesús
  • Crevillén, Pedro
  • Jarillo, José A
  • Piñeiro, Manuel
INHIBITOR OF GROWTH (ING) proteins are chromatin readers that bind trimethylated histone H3 lysine (K) 4 (H3K4me3) marks and associate with either histone acetyltransferase or deacetylase complexes to activate or repress gene transcription, respectively. In plants, there are two types of ING proteins, namely ING1 and ING2. Here, we report that Arabidopsis thaliana ING2 associates with multiple subunits of the histone H4 acetyltransferase complex NuA4, controls genome-wide levels of histone H4 acetylation (H4ac), and regulates different developmental processes, including the initiation of flowering. Our data indicate that ING2 biological functions are largely independent of ING1 activity. We find that ING2 is recruited to the chromatin of key floral integrators, such as FT and SOC1, and is required for their timely activation by modulating histone H4ac levels at these loci. Our observations reveal a genetic interaction between ING2 and genes encoding relevant proteins for H3K4me3 or H2A.Z deposition, suggesting that ING2 might represent a hub for potential crosstalk between histone H4ac and these histone modifications/variants.
Repisalud
Publication Artículo científico (JournalArticle)

Microbiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow.

  • Robles-Vera, Iñaki
  • Jarit-Cabanillas, Aitor
  • Brandi, Paola
  • Martínez-López, María
  • Martínez-Cano, Sarai
  • Rodrigo-Tapias, Manuel
  • Femenía-Muiña, Marcos
  • Redondo-Urzainqui, Ana
  • Nuñez, Vanesa
  • González-Correa, Cristina
  • Moleón, Javier
  • Duarte, Juan
  • Conejero, Laura
  • Mata-Martínez, Pablo
  • Díez-Rivero, Carmen María
  • Bergón-Gutiérrez, Marta
  • Fernández-López, Iván
  • Gómez, Manuel J
  • Quintas, Ana
  • Dopazo, Ana
  • Sánchez-Cabo, Fátima
  • Pariente, Esther
  • Del Fresno, Carlos
  • Subiza, José Luis
  • Iborra, Salvador
  • Sancho, David
Impairment of the intestinal barrier allows the systemic translocation of commensal bacteria, inducing a proinflammatory state in the host. Here, we investigated innate immune responses following increased gut permeability upon administration of dextran sulfate sodium (DSS) in mice. We found that Enterococcus faecalis translocated to the bone marrow following DSS treatment and induced trained immunity (TI) hallmarks in bone-marrow-derived mouse macrophages and human monocytes. DSS treatment or heat-killed E. faecalis reprogrammed bone marrow progenitors (BMPs), resulting in enhanced inflammatory responses in vitro and in vivo and protection against subsequent pathogen infections. The C-type lectin receptor Mincle (Clec4e) was essential for E. faecalis-induced TI in BMPs. Clec4e mice showed impaired TI upon E. faecalis administration and reduced pathology following DSS treatment. Thus, Mincle sensing of E. faecalis induces TI that may have long-term effects on pathologies associated with increased gut permeability.
Repisalud
Publication Artículo científico (JournalArticle)

cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.

  • Galán, Miguel
  • Fernández-Méndez, Laura
  • Núñez, Vanessa
  • Femenía-Muiña, Marcos
  • Figuera-Belmonte, Pau
  • Moya-Ruiz, Elena
  • Martínez-Cano, Sarai
  • Hernández-García, Elena
  • Rodrigo-Tapias, Manuel
  • Rodríguez-Ronchel, Ana
  • Relaño-Rupérez, Carlos
  • Wculek, Stefanie K
  • Benguria, Alberto
  • Dopazo, Ana
  • Henri, Sandrine
  • Jo, Suin
  • Liu, Tian-Tian
  • Malissen, Bernard
  • Murphy, Kenneth M
  • Ramiro, Almudena R
  • Carregal-Romero, Susana
  • Ruiz-Cabello, Jesús
  • Robles-Vera, Iñaki
  • Sancho, David
Atherosclerosis is characterized by immune cell accumulation in the arterial wall and adaptive CD4 T helper 1 immunity contributes to atherosclerosis development. However, how conventional dendritic cells (DCs) orchestrate this adaptive response remains controversial. This study unveils strategies for the gain and loss of function of cDCs to decipher their role in atherosclerosis induction in relation to adaptive T-cell immunity. We tested atherosclerosis in mice fed a high-cholesterol diet (HCD). Expansion of DCs in vivo was achieved by overexpression of FLT3L (Fms-like tyrosine kinase 3 ligand), while the effect of ablation of conventional type 1 DCs (cDC1s) in atherosclerosis was analyzed by grafting bone marrow from different mouse models of cDC1 depletion, including and Δ32 mice, into lethally irradiated recipients before HCD. CD3 T-cell subsets were analyzed using flow cytometry or single-cell RNA sequencing (scRNA-seq). Nanoparticles loaded with dexamethasone and decorated with anti-CLEC9A antibody to target cDC1s were tested for immunotherapy. Expansion of DCs in mice fed HCD for 8 weeks led to increased atherosclerotic lesion, which was prevented when mice were grafted before DC expansion with cDC1-depleted bone marrow compared with controls. Consistently, even in the absence of DC expansion, cDC1 deficiency prevented HCD-induced atherosclerosis. The scRNA-seq analysis of aortic CD3 T cells in this experimental approach showed a local reduction in CD4 Th1 and CD8 IFN (interferon)-γ T cells in the absence of cDC1s compared with control mice. Mechanistically, stimulator of IFN genes (STING) in cDC1s was required for the proatherogenic function of cDC1s. As a potential cDC1-targeted immunotherapy for atherosclerosis, we generated lipid nanoparticles decorated with an anti-CLEC9A antibody to specifically target cDC1s. When loaded with the immunosuppressive drug dexamethasone, these nanoparticles promoted a reduction of the atherosclerotic lesion in mice fed HCD, correlating with decreased CD4 Th1 and CD8 IFN-γ T cells in the spleen. These immunosuppressive nanoparticles, however, did not impair antiviral response. Using state-of-the-art strategies, our results establish that cDC1s have a proatherogenic role in atherosclerosis by boosting CD4 and CD8 T-cell immunity and propose that cDC1s can be targeted with an immunosuppressive drug to decrease atherosclerosis progression.
Repisalud
Publication Artículo científico (JournalArticle)

Mitochondrial response to fever boosts T1-driven inflammatory responses.

  • Dunphy, Gillian
  • Sancho, David
Increased body temperature, both locally and systemically, is a key feature of the inflammatory response. Heat is associated with increased blood flow to affected areas and increased immune infiltrate, yet increased temperature has also been described to have direct effects on immune cell function. In a recent study, Heintzman, et al investigated the effect of febrile temperature (39 °C) on T cell function. They describe increased T1 function and fitness accompanied by a decrease in regulatory T cell suppressive function. These findings add another important consequence to our understanding of fever responses.
Repisalud
Publication Artículo científico (JournalArticle)

Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse.

  • Heras-Murillo, Ignacio
  • Mañanes, Diego
  • Munné, Pablo
  • Núñez, Vanessa
  • Herrera, Jessica
  • Catalá-Montoro, Mauro
  • Alvarez, Maite
  • Del Pozo, Miguel A
  • Melero, Ignacio
  • Wculek, Stefanie K
  • Sancho, David
The potential of dendritic cell (DC) vaccination against cancer is not fully achieved. Little is known about the precise nature of the anti-cancer immune response triggered by different natural DC subsets and their relevance in preventing postsurgical tumor recurrence. Here, we use mouse splenic conventional DC1s (cDC1s) or cDC2s pulsed with tumor cell lysates to generate DC vaccines. cDC1-based vaccination induces a stronger effector and memory CD4 and CD8 anti-tumor T cell response, leading to a better control of tumors treated either therapeutically or prophylactically. Using an experimental model of tumor relapse, we show that adjuvant or neoadjuvant cDC1 vaccination improves anti-tumor immune memory, particularly by increasing the infiltrates of CD4 tissue resident memory (Trm) and CD8 memory T cells. This translates into complete prevention of tumor relapses. Moreover, elevated abundance of cDC1s positively correlates with CD4 Trm presence, and both associate with enhanced survival in human breast cancer and melanoma. Our findings suggest that cDC1-based vaccination excels at immune memory induction and prevention of cancer recurrence.
Repisalud
Publication Artículo científico (JournalArticle)

Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET.

  • Nogales, Paula
  • Velasco, Carlos
  • González-Cintado, Leticia
  • Sharysh, Diana
  • Mota-Cobián, Adriana
  • Izquierdo-Serrano, Raúl
  • Torroja, Carlos
  • Del Rio-Aledo, David
  • Morales-Cano, Daniel
  • Mota, Rubén A
  • Benguría, Alberto
  • Dopazo, Ana
  • Sánchez-Cabo, Fátima
  • Vázquez, Jesús
  • España, Samuel
  • Carramolino, Laura
  • Mateo, Jesús
  • Bentzon, Jacob F
Positron emission tomography (PET) imaging with the radiolabeled glucose analog fluorodeoxyglucose (FDG) is used to monitor atherosclerosis in clinical trials, but there is uncertainty regarding the plaque cell types that accumulate FDG and how uptake is regulated. The long-standing view that FDG is mainly taken up by macrophages is at odds with human and experimental data, and the impact of disease activity on FDG uptake has not been examined directly. To analyze the ability of FDG-PET to monitor disease activity, we developed a model of plaque regression in minipigs with hepatic overexpression of a gain-of-function mutant of (). Atherosclerosis was induced through 12 months of high-fat feeding in the porcine model. Disease activity was then lowered for 3 months by reducing plasma cholesterol with a low-fat diet alone or in combination with the microsomal transfer protein (MTP) inhibitor BMS-212122. Plaque regression in advanced lesions of the abdominal aorta was evident from reduced lipid content, reduced necrotic core size, and partial resolution of plaque inflammation and was accompanied by a decline in FDG-PET signal. Single-cell gene expression profiling revealed that plaque regression involved substantial down-regulation of genes encoding glycolytic enzymes in smooth muscle cells (SMCs), macrophages, and lymphocytes, which was corroborated by analysis of the plaque cellular proteome. These findings in a large-animal model suggest that FDG-PET can monitor atherosclerosis because of a close association between disease activity and glycolytic enzyme expression in all of the major plaque cell types.
Repisalud
Publication Artículo científico (JournalArticle)

The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease.

  • Santiago-Hernandez, Aranzazu
  • Martin-Lorenzo, Marta
  • Gómez-Serrano, María
  • Lopez, Juan Antonio
  • Martin-Blazquez, Ariadna
  • Vellosillo, Perceval
  • Minguez, Pablo
  • Martinez, Paula J
  • Vázquez, Jesús
  • Ruiz-Hurtado, Gema
  • Barderas, Maria G
  • Sarafidis, Pantelis
  • Segura, Julian
  • Ruilope, Luis M
  • Alvarez-Llamas, Gloria
Early diagnosis and treatment of chronic kidney disease (CKD) is a worldwide challenge. Subjects with albumin-to-creatinine ratio (ACR) ≥ 30 mg/g and preserved renal function are considered to be at no cardiorenal risk in clinical practice, but prospective clinical studies evidence increased risk, even at the high-normal (HN) ACR range (10-30 mg/g), supporting the need to identify other molecular indicators for early assessment of patients at higher risk. Following our previous studies, here we aim to stratify the normoalbuminuria range according to cardiorenal risk and identify the glycoproteins and N-glycosylation sites associated with kidney damage in subclinical CKD. Glycoproteins were analyzed in urine from hypertensive patients within the HN ACR range compared to control group (C; ACR < 10 mg/g) by mass spectrometry. A different cohort was analyzed for confirmation (ELISA) and sex perspective was evaluated. Patients' follow-up for 8 years since basal urine collection revealed higher renal function decline and ACR progression for HN patients. Differential N-glycopeptides and their N -glycosylation sites were also identified, together with their pathogenicity. N-glycosylation may condition pathological protein deregulation, and a panel of 62 glycoproteins evidenced alteration in normoalbuminuric subjects within the HN range. Haptoglobin-related protein, haptoglobin, afamin, transferrin, and immunoglobulin heavy constant gamma 1 (IGHG1) and 2 (IGHG2) showed increased levels in HN patients, pointing to disturbed iron metabolism and tubular reabsorption and supporting the tubule as a target of interest in the early progression of CKD. When analyzed separately, haptoglobin, afamin, transferrin, and IGHG2 remained significant in HN, in both women and men. At the peptide level, 172 N-glycopeptides showed differential abundance in HN patients, and 26 showed high pathogenicity, 10 of them belonging to glycoproteins that do not show variation between HN and C groups. This study highlights the value of glycosylation in subjects not meeting KDIGO criteria for CKD. The identified N-glycopeptides and glycosylation sites showed novel targets, for both the early assessment of individual cardiorenal risk and for intervention aimed at anticipating CKD progression.
Repisalud
Publication Artículo científico (JournalArticle)

Phosphatase-independent activity of smooth-muscle calcineurin orchestrates a gene expression program leading to hypertension.

  • Yunes-Leites, Paula Sofía
  • Sun, Yilin
  • Martínez-Martínez, Sara
  • Alfayate, Álvaro
  • Toral, Marta
  • Méndez-Olivares, María José
  • Colmenar, Ángel
  • Torralbo, Ana Isabel
  • López-Maderuelo, Dolores
  • Mateos-García, Sergio
  • Cornfield, David N
  • Vázquez, Jesús
  • Redondo, Juan Miguel
  • Campanero, Miguel R
Angiotensin-II (Ang-II) drives pathological vascular wall remodeling in hypertension and abdominal aortic aneurysm (AAA) through mechanisms that are not completely understood. Previous studies showed that the phosphatase activity of calcineurin (Cn) mediates Ang-II-induced AAA, but the cell type involved in the action of Cn in AAA formation remained unknown. Here, by employing newly created smooth muscle cell (SMC)-specific and endothelial cell (EC)-specific Cn-deficient mice (SM-Cn-/- and EC-Cn-/- mice), we show that Cn expressed in SMCs, but not ECs, was required for Ang-II-induced AAA. Unexpectedly, SMC Cn also played a structural role in the early onset and maintenance of Ang-II-induced hypertension, independently of its known phosphatase activity. Among the signaling pathways activated by Ang-II, Cn signaling is essential in SMCs, as nearly 90% of the genes regulated by Ang-II in the aorta required Cn expression in SMCs. Cn orchestrated, independently of its enzymatic activity, the induction by Ang-II of a transcriptional program closely related to SMC contractility and hypertension. Cn deletion in SMCs, but not its pharmacological inhibition, impaired the regulation of arterial contractility. Among the genes whose regulation by Ang-II required Cn expression but not its phosphatase activity, we discovered that Serpine1 was critical for Ang-II-induced hypertension. Indeed, pharmacological inhibition of PAI-1, the protein encoded by Serpine1, impaired SMCs contractility and readily regressed hypertension. Mechanistically, Serpine1 induction was mediated by Smad2 activation via the structural role of Cn. These findings uncover an unexpected role for Cn in vascular pathophysiology and highlight PAI-1 as a potential therapeutic target for hypertension.
Repisalud
Publication Artículo científico (JournalArticle)

Polymeric immunoglobulin receptor deficiency attenuates experimental atherosclerosis.

  • Cerro-Pardo, Isabel
  • Picatoste, Belén
  • Raposo-Gutiérrez, Irene
  • Martos-Folgado, Inmaculada
  • Márquez-Gálvez, Cristina
  • García-García, Ana
  • Ortega-Villanueva, Lucía
  • Mur, Sonia M
  • Robles-Vera, Iñaki
  • Escolà-Gil, Joan Carles
  • Núñez, Estefanía
  • Sancho, David
  • Lindholt, Jes
  • Vázquez, Jesús
  • Blanco-Colio, Luis Miguel
  • Ramiro, Almudena R
  • Martín-Ventura, José Luis
Polymeric immunoglobulin receptor (PIGR) is a transmembrane protein widely expressed in mucosal epithelial cells that is involved in the transcytosis of the polymeric immunoglobulins IgA and IgM. Recent findings revealed increased plasma PIGR levels in subjects with subclinical atherosclerosis, although its function remains uncertain. To assess the role of PIGR in atherosclerosis. We analyzed PIGR levels in human atherosclerotic plaques compared to healthy aortic samples, as well as in the serum of subjects with peripheral arterial disease (PAD) and controls. Next, we studied the effect of germline deficiency in experimental atherosclerosis ( mice fed a western-diet for 10 weeks). Circulating IgA and IgM levels, as well as B and T cell numbers in spleen and Peyer's patches (PP), were analyzed by ELISA and flow cytometry, respectively. PIGR levels were increased in the intima of early human atherosclerotic lesions and in patients with PAD, compared to controls. mice showed elevated serum IgA and IgM levels, along with an increased number of germinal center B cells in both the spleen and PP. Moreover, mice displayed a significantly reduced plaque size in the aortic sinus and a strong decrease in foam cells (CD68), while no changes were observed in contractile smooth muscle cells (α-actin) and collagen content compared to control mice. Global deficiency decreases atherosclerosis, suggesting that PIGR blockade may have beneficial effects in vascular pathologies.
Repisalud
Publication Artículo científico (JournalArticle)

A Multiplexed Quantitative Proteomics Approach to the Human Plasma Protein Signature.

  • Núñez, Estefanía
  • Gómez-Serrano, María
  • Calvo, Enrique
  • Bonzon-Kulichenko, Elena
  • Trevisan-Herraz, Marco
  • Rodríguez, José Manuel
  • García-Marqués, Fernando
  • Magni, Ricardo
  • Lara-Pezzi, Enrique
  • Martín-Ventura, José Luis
  • Camafeita, Emilio
  • Vázquez, Jesús
Despite the plasma proteome being able to provide a unique insight into the health and disease status of individuals, holding singular promise as a source of protein biomarkers that could be pivotal in the context of personalized medicine, only around 100 proteins covering a few human conditions have been approved as biomarkers by the US Food and Drug Administration (FDA) so far. Mass spectrometry (MS) currently has enormous potential for high-throughput analysis in clinical research; however, plasma proteomics remains challenging mainly due to the wide dynamic range of plasma protein abundances and the time-consuming procedures required. We applied a new MS-based multiplexed proteomics workflow to quantitate proteins, encompassing 67 FDA-approved biomarkers, in >1300 human plasma samples from a clinical cohort. Our results indicate that this workflow is suitable for large-scale clinical studies, showing good accuracy and reproducibility (coefficient of variation (CV) < 20 for 90% of the proteins). Furthermore, we identified plasma signature proteins (stable in time on an individual basis), stable proteins (exhibiting low biological variability and high temporal stability), and highly variable proteins (with low temporal stability) that can be used for personalized health monitoring and medicine.
Repisalud
Publication Artículo científico (JournalArticle)

In-gel protein digestion using acidic methanol produces a highly selective methylation of glutamic acid residues.

  • Lozano-Prieto, Marta
  • Camafeita, Emilio
  • Jorge, Inmaculada
  • Laguillo-Gómez, Andrea
  • Barrero-Rodríguez, Rafael
  • Devesa, Cristina A
  • Pertusa, Clara
  • Calvo, Enrique
  • Sánchez-Madrid, Francisco
  • Vázquez, Jesús
  • Martin-Cofreces, Noa B
Mass-tolerant open search methods allow the high-throughput analysis of modified peptides by mass spectrometry. These techniques have paved the way to unbiased analysis of post-translational modifications in biological contexts, as well as of chemical modifications produced during the manipulation of protein samples. In this work, we have analyzed in-depth a wide variety of samples of different biological origin, including cells, extracellular vesicles, secretomes, centrosomes and tissue preparations, using Comet-ReCom, a recently improved version of the open search engine Comet-PTM. Our results demonstrate that glutamic acid residues undergo intensive methyl esterification when protein digestion is performed using in-gel techniques, but not using gel-free approaches. This effect was highly specific to Glu and was not found for other methylable residues such as Asp.
Repisalud
Publication Artículo científico (JournalArticle)

Imidazole propionate is a driver and therapeutic target in atherosclerosis.

  • Mastrangelo, Annalaura
  • Robles-Vera, Iñaki
  • Mañanes, Diego
  • Galán, Miguel
  • Femenía-Muiña, Marcos
  • Redondo-Urzainqui, Ana
  • Barrero-Rodríguez, Rafael
  • Papaioannou, Eleftheria
  • Amores-Iniesta, Joaquín
  • Devesa, Ana
  • Lobo-González, Manuel
  • Carreras, Alba
  • Beck, Katharina R
  • Ivarsson, Sophie
  • Gummesson, Anders
  • Georgiopoulos, Georgios
  • Rodrigo-Tapias, Manuel
  • Martínez-Cano, Sarai
  • Fernández-López, Ivan
  • Nuñez, Vanessa
  • Ferrarini, Alessia
  • Inohara, Naohiro
  • Stamatelopoulos, Kimon
  • Benguría, Alberto
  • Cibrian, Danay
  • Sánchez-Madrid, Francisco
  • Alonso-Herranz, Vanesa
  • Dopazo, Ana
  • Barbas, Coral
  • Vázquez, Jesús
  • López, Juan Antonio
  • González-Martín, Alicia
  • Nuñez, Gabriel
  • Stellos, Konstantinos
  • Bergström, Göran
  • Bäckhed, Fredrik
  • Fuster, Valentín
  • Ibañez, Borja
  • Sancho, David
Atherosclerosis is the main underlying cause of cardiovascular diseases. Its prevention is based on the detection and treatment of traditional cardiovascular risk factors. However, individuals at risk for early vascular disease often remain unidentified. Recent research has identified new molecules in the pathophysiology of atherosclerosis, highlighting the need for alternative disease biomarkers and therapeutic targets to improve early diagnosis and therapy efficacy. Here, we observed that imidazole propionate (ImP), produced by microorganisms, is associated with the extent of atherosclerosis in mice and in two independent human cohorts. Furthermore, ImP administration to atherosclerosis-prone mice fed with chow diet was sufficient to induce atherosclerosis without altering the lipid profile, and was linked to activation of both systemic and local innate and adaptive immunity and inflammation. Specifically, we found that ImP caused atherosclerosis through the imidazoline-1 receptor (I1R, also known as nischarin) in myeloid cells. Blocking this ImP-I1R axis inhibited the development of atherosclerosis induced by ImP or high-cholesterol diet in mice. Identification of the strong association of ImP with active atherosclerosis and the contribution of the ImP-I1R axis to disease progression opens new avenues for improving the early diagnosis and personalized therapy of atherosclerosis.
Repisalud
Publication Artículo científico (JournalArticle)

Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis.

  • Nikolic, Ivana
  • Ruiz-Garrido, Irene
  • Crespo, María
  • Romero-Becerra, Rafael
  • Leiva-Vega, Luis
  • Mora, Alfonso
  • León, Marta
  • Rodríguez, Elena
  • Leiva, Magdalena
  • Plata-Gómez, Ana Belén
  • Alvarez Flores, Maria Beatriz
  • Torres, Jorge L
  • Hernández-Cosido, Lourdes
  • López, Juan Antonio
  • Vázquez, Jesús
  • Efeyan, Alejo
  • Martin, Pilar
  • Marcos, Miguel
  • Sabio, Guadalupe
Obesity is characterized by low-grade inflammation, energy imbalance and impaired thermogenesis. The role of regulatory T cells (Treg) in inflammation-mediated maladaptive thermogenesis is not well established. Here, we find that the p38 pathway is a key regulator of T cell-mediated adipose tissue (AT) inflammation and browning. Mice with T cells specifically lacking the p38 activators MKK3/6 are protected against diet-induced obesity, leading to an improved metabolic profile, increased browning, and enhanced thermogenesis. We identify IL-35 as a driver of adipocyte thermogenic program through the ATF2/UCP1/FGF21 pathway. IL-35 limits CD8 T cell infiltration and inflammation in AT. Interestingly, we find that IL-35 levels are reduced in visceral fat from obese patients. Mechanistically, we demonstrate that p38 controls the expression of IL-35 in human and mouse Treg cells through mTOR pathway activation. Our findings highlight p38 signaling as a molecular orchestrator of AT T cell accumulation and function.
Repisalud
Publication Artículo científico (JournalArticle)

Immunoglobulin A/PIGR axis as potential mediators of human abdominal aortic aneurysms revealed by topologically resolved proteomics.

  • Cerro-Pardo, Isabel
  • Núñez, Estefanía
  • Picatoste, Belén
  • Márquez-Gálvez, Cristina
  • Ortega-Villanueva, Lucía
  • Raposo-Gutiérrez, Irene
  • Lindholt, Jes S
  • Blanco-Colio, Luis Miguel
  • Ramiro, Almudena R
  • Vázquez, Jesús
  • Martín-Ventura, José Luis
Abdominal aortic aneurysm (AAA) is an asymptomatic chronic disease of the aorta and its evolution is unpredictable. Despite the existence of several pathological mechanisms contributing to the dilation of the human AAA wall, there is currently no specific therapy to prevent the fatal rupture of the aorta. Our objective was to identify novel mediators and/or biomarkers involved in the instability of the aortic wall that could help to prevent AAA progression. Multiplexed quantitative proteomic analysis of human AAA and healthy aortic wall (medial and adventitial layers) was performed. Results were subsequently validated by western blot and immunohistochemistry, as well as by turbidimetry/ELISA of tissue-conditioned media. In addition, immunoglobulins A1 and A2 (IGA1 and IGA2) plasma levels were analyzed by turbidimetry in a pilot study [controls (n = 22) and AAA patients (n = 22)] and in a validation study with a 6-year follow-up [controls (n = 64) and AAA patients (n = 189)]. In vitro experiments were performed in THP-1-derived macrophages (basal or polarized to M1 or M2). Polymeric immunoglobulin receptor (PIGR) mRNA expression and secretion in macrophages were analyzed by Q-PCR and ELISA, respectively. Finally, the hematopoietic contribution of PIGR was assessed in experimental AAA (Ldlr mice fed an atherogenic diet and 1 μg/Kg/min angiotensin II infusion for 28 days) by bone marrow transplantation experiments. Functional analysis of biological pathways altered in human AAA wall revealed a significant upregulation of components of the adaptive immune response, including IGHA1 and IGHA2, as well as the IGA receptor, PIGR. In addition, IGA2, but not IGA1, plasma levels were significantly increased in a pilot study of AAA patients relative to controls (489 ± 38 vs 344 ± 36 mg/L, p < 0.01). This finding was further validated in a larger cohort, confirming the association of IGA2 with AAA presence independent of risk factors and treatments [OR = 2.140 (1.109-4.130), P < 0.05]. Furthermore, in the validation cohort, elevated IGA2 plasma levels were independently associated with AAA progression [HR = 1.941 (1.108-3.399), p < 0.05]. PIGR colocalized with macrophages in the AAA wall and, PIGR mRNA levels were increased following the differentiation of THP-1 monocytes into macrophages, as well as in M1-polarized THP-1 macrophages compared to M2 macrophages. Pigr deficiency in hematopoietic cells resulted in a significantly reduced AAA incidence (14 vs 57%) and decreased macrophage infiltration (3.5 ± 0.5 vs 5.6 ± 0.7%). Increased IGA and PIGR is observed in the AAA wall. Pigr deficiency in hematopoietic cells decreases AAA progression, suggesting a therapeutic role for PIGR in AAA.
Repisalud
Publication Artículo científico (JournalArticle)

A New GlyT2 Variant Associated with Hyperekplexia.

  • Sarmiento-Jiménez, Jorge
  • Felipe, Raquel
  • Núñez, Enrique
  • Ferrando-Muñoz, Alejandro
  • Benito-Muñoz, Cristina
  • Gago, Federico
  • Vázquez, Jesús
  • Camafeita, Emilio
  • Clement, Emma
  • Wilson, Brian
  • López-Corcuera, Beatriz
Hyperekplexia (OMIM 149400), a sensorimotor syndrome of perinatal clinical relevance, causes newborns to display an energic startle reflex in response to certain trivial stimuli. This condition can be lethal due to apnea episodes. The disease is caused by a blockade of glycinergic neurotransmission. Glycinergic interneurons preserve their identity by the activity of the surface glycine transporter GlyT2, which supplies glycine to presynaptic terminals to maintain glycine content in synaptic vesicles. Loss-of-function mutations in the GlyT2 gene () cause a presynaptic form of human hyperekplexia. Here, we describe a new GlyT2 variant found in an infantile patient diagnosed with hyperekplexia. A missense mutation in the open reading frame of the GlyT2 gene inherited in homozygosity caused the substitution G449E in a residue highly conserved across the phylogenetic scale. The sequences of the glycine receptor genes and did not show abnormalities. We expressed the recombinant GlyT2 variant in heterologous cells and analyzed its pathogenic mechanism. The transporter was totally inactive, behaving as a bona fide loss-of-function mutant. Furthermore, the mutation promoted the abnormal insertion of the protein into the membrane, leading to its large incorporation into lipid rafts. However, there was no apparent alteration of wild-type trafficking upon mutant coexpression, as the mutant was prematurely degraded from the endoplasmic reticulum. Rescue with chemical chaperones was not possible for this mutant. Proteomics demonstrated that the expression of the mutant induced the unfolded protein response and interfered with raft-dependent processes. Therefore, the new variant causes a loss of function regarding GlyT2 activity but a gain of function as a cell proteostasis disturber.
Repisalud
Publication Artículo científico (JournalArticle)

An audit of the PeptideAtlas database uncovers evidence for repurposed pseudogenes and co-opted retroviral ORFs.

  • Rodriguez, Jose Manuel
  • Maquedano, Miguel
  • Cerdán-Vélez, Daniel
  • Laguillo-Gómez, Andrea
  • Calvo, Enrique
  • Abascal, Federico
  • Vázquez, Jesús
  • Tress, Michael L
The human genome has been the subject of scrutiny for more than two decades, yet new protein coding genes are still being uncovered. Recently ribosome profiling experiments have provided evidence for the translation of thousands of novel open reading frames (ORFs). To determine how many of these novel ORFs have peptide support, we carried out an in-depth investigation of an entire mass spectrometry proteomics database. We analysed the peptides housed in the human build of the PeptideAtlas database and identified reliable evidence for 35 potential coding genes not annotated in the Ensembl/GENCODE reference gene set. Evidence from complementary sources confirmed that 16 were almost certainly coding genes, but we believe that at least 14 are most likely to be undergoing aberrant translation. These 14 genes had reading frames that were not preserved beyond human and their peptides were restricted to cancers or cell lines. Remarkably, three of the sixteen likely coding genes were derived from endogenous retroviral ORFs and were expressed only in placenta. All three had evidence of purifying selection. Retroviral ORFs (syncytins) with distinct origins are expressed in almost all mammalian placentae and these results suggest that co-opted ORFs may also play an important role in placental development. Our analysis shows that proteomics data can be used in conjunction with evolutionary evidence to confirm the existence of new coding genes. The evidence suggests that both testis and placenta are the tissues most likely to express still to be identified coding genes, and that there may be other transposon-derived ORF that have been co-opted as coding genes. The strong evidence for the translation of regions under dysregulated conditions has important implications for the annotation of coding genes and in the analysis of cancer and other degenerative diseases.The online version contains supplementary material available at 10.1186/s12864-025-12238-w.
Repisalud
Publication Artículo científico (JournalArticle)

Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4.

  • Borràs, Carla
  • Canyelles, Marina
  • Santos, David
  • Rotllan, Noemí
  • Núñez, Estefanía
  • Vázquez, Jesús
  • Maspoch, Daniel
  • Cano-Sarabia, Mary
  • Zhao, Qi
  • Carmona-Iragui, Maria
  • Sirisi, Sònia
  • Lleó, Alberto
  • Fortea, Juan
  • Alcolea, Daniel
  • Blanco-Vaca, Francisco
  • Escolà-Gil, Joan Carles
  • Tondo, Mireia
In the central nervous system, apolipoprotein (APO)E-containing lipoprotein particles mediate the transport of glial-derived cholesterol to neurons, which is essential for neuronal membrane remodeling and maintenance of the myelin sheath. We aimed to examine cholesterol transport via lipoprotein particles in cerebrospinal fluid (CSF) of Alzheimer's disease (AD) patients compared to control individuals. Additionally, we explored the ability of reconstituted HDL containing different APOE isoforms to regulate cholesterol transport. We evaluated the capacity of CSF lipoprotein particles to facilitate radiolabeled unesterified cholesterol efflux from A172 human glioblastoma astrocytes and to deliver cholesterol to SH-SY5Y human neuronal cells. The CSF lipoprotein proteome was analyzed by LC-MS/MS. Reconstituted HDL nanoparticles were prepared by combining phospholipids and cholesterol with human APOE3 or APOE4, followed by radiolabeling with unesterified cholesterol. Our results showed that cholesterol efflux from astrocytes to CSF were similar between AD patients and controls, both under baseline conditions and after activation of ABCA1 and ABCG1. However, CSF lipoprotein-mediated neuronal cholesterol uptake was significantly reduced in the AD group. LC-MS/MS analysis identified 239 proteins associated with CSF lipoproteins in both groups, with no major alterations in proteins linked to cholesterol metabolism. However, 27 proteins involved in noncholesterol-related processes were differentially expressed. Notably, synthetic reconstituted HDL particles containing APOE4 exhibited reduced capacity to deliver cholesterol to neurons compared to those with APOE3. These findings indicate that CSF lipoproteins from patients with AD demonstrate impaired cholesterol delivery to neurons. Our study highlights APOE4 as a critical contributor to abnormal neuronal cholesterol uptake in AD pathophysiology.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Nanoparticle to Nanoparticle Bioorthogonal Detection of Atherosclerosis

  • Muñoz-Hernando, María
  • Nogales, Paula
  • Rodríguez-San Pedro, Andrea
  • Ibañez, Marta
  • Morcillo, Miguel Ángel
  • González-Cintado, Leticia
  • Bentzon, Jacob F
  • Herranz, Fernando
In vivo identification and characterization of atherosclerosis is a promising approach for the development of novel therapies and personalized treatments. Among the methods for this in vivo identification, the use of pretargeted imaging shows very large probe uptakes and excellent selectivity. However, this approach relies on the use of antibodies which may limit their usability. In this study, we introduce a pretargeting imaging approach for atherosclerosis detection using PET that only employs nanomaterials. Here we develop the concept of nanoparticle-to-nanoparticle pretargeted imaging for atherosclerosis. Sphingomyelin solid lipid nanoparticles (sphNP) functionalized with trans-cyclooctene (TCO) were used as targeting agents and accumulated in atherosclerotic plaques. This was followed by the injection of 68Ga-doped nanotracers functionalized with tetrazine ([68Ga]Ga-IONP-Tz), which binds to the accumulated sphNP-TCO via bioorthogonal click chemistry. In vivo PET imaging showed clear uptake in the aortic arch of mice receiving the full pretargeting approach, while the control groups showed no significant signal. This nanoparticle-based pretargeting strategy enables noninvasive PET imaging of atherosclerosis without using antibodies. This approach expands the use of bioorthogonal imaging and may have potential for targeted drug delivery to atherosclerotic plaques., We acknowledge funding from the Spanish Ministry of Science and Innovation (PDC2022−133493−100, RED2022−134299- T, PID2019−104059RB-100), Comunidad de Madrid (P2022/BMD-7333), Conexion Nanomedicina CSIC, and European Research Council under the European Union’s Horizon 2020 research and innovation program (grant no. 866240). CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020−001041-S funded by MICIN/ AEI/10.13039/501100011033)., Peer reviewed